Furthermore, EGFR is overexpressed in approximately 90–100% of SCCHN specimens and has been associated with worse prognosis, including advanced stage, poorly differentiated tumours and poor survival (Santini et al 1991; Dassonville et al, 1993). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.